Management of symptoms in step-down therapy of gastroesophageal reflux disease

Objective: Majority of studies on gastroesophageal reflux disease (GERD) that include patients with or without erosive disease have documented the efficacy of proton pump inhibitors (PPIs) as well as their superiority to H2‐receptor antagonist (H2‐RA). The purpose of this study was to clarify the d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of gastroenterology and hepatology 2005-09, Vol.20 (9), p.1365-1370
Hauptverfasser:	MINE, SHINICHIRO, IIDA, TAKESHI, TABATA, TAKAHIRO, KISHIKAWA, HIROFUMI, TANAKA, YOSHIYA
Format:	Artikel
Sprache:	eng
Schlagworte:	2-Pyridinylmethylsulfinylbenzimidazoles Aged Biological and medical sciences Deglutition Disorders - drug therapy Endosonography Enzyme Inhibitors - therapeutic use Esophagitis, Peptic - diagnostic imaging Esophagitis, Peptic - drug therapy Esophagitis, Peptic - etiology Esophagus Famotidine - therapeutic use Female Gastroenterology. Liver. Pancreas. Abdomen Gastroesophageal Reflux - complications Gastroesophageal Reflux - diagnostic imaging Gastroesophageal Reflux - drug therapy gastroesophageal reflux disease H2-receptor antagonist Heartburn - drug therapy Histamine H2 Antagonists - therapeutic use Humans Lansoprazole Male Medical sciences Middle Aged Omeprazole - analogs & derivatives Omeprazole - therapeutic use Other diseases. Semiology Proton Pump Inhibitors Quality of Life Recurrence Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!